Suchergebnisse - "V92SO9WP2I"

PubPharm (251)

1

Effect of neuromuscular reversal with neostigmine/glycopyrrolate versus sugammadex on postoperative ileus following colorectal surgery

enthalten in: Techniques in coloproctology | 2023

von Traeger, L. | Hall, T. | Bedrikovetski, S. | +4

2

Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score-Inverse Probability of Treatment Weighting Cohort Study

enthalten in: Chest | 2021

von Wang, M. | Lai, J. | Huang, Y. | +6

CommentIn: Chest. 2021 Oct;160(4):1157-1159. - PMID 34625159

3

Population Pharmacokinetic Analysis of Indacaterol/Glycopyrronium/Mometasone Furoate After Administration of Combination Therapies Using the Breezhaler® Device in Patients with Asthma

enthalten in: European journal of drug metabolism and pharmacokinetics | 2021

von Bartels, C. | Jain, M. | Yu, J. | +2

4

Effects of (a Combination of) the Beta2-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction

enthalten in: Cells | 2021

von Maarsingh, H. | Oldenburger, A. | Han, B. | +6

5

Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease : Methodological Considerations in the Mortality Effect

enthalten in: American journal of respiratory and critical care medicine | 2021

von López-Campos, J. | Fernández-Villar, A. | Ruano-Ravina, A.

6

Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD : the TRIVERSYTI randomised controlled trial

enthalten in: Respiratory research | 2021

von Zheng, J. | Baldi, S. | Zhao, L. | +7

7

Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM) : a randomised, double-blind, controlled phase 3 study

enthalten in: The Lancet. Respiratory medicine | 2020

von Kerstjens, H. | Maspero, J. | Chapman, K. | +8

8

Long-acting dual bronchodilator therapy (indacaterol/glycopyrronium) versus nebulized short-acting dual bronchodilator (salbutamol/ipratropium) in chronic obstructive pulmonary disease : A double-blind, randomized, placebo-controlled trial

enthalten in: Respiratory medicine | 2020

von van Geffen, W. | Carpaij, O. | Westbroek, L. | +4

9

Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD : A Systematic Literature Review and Network Meta-analysis

enthalten in: Advances in therapy | 2020

von Ferguson, G. | Darken, P. | Ballal, S. | +5

10

Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long-acting bronchodilator-naïve COPD patients : A pooled analysis

enthalten in: Respirology (Carlton, Vic.) | 2020

von Muro, S. | Yoshisue, H. | Kostikas, K. | +3

CommentIn: Respirology. 2020 Apr;25(4):352-353. - PMID 31556195

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]